| __timestamp | Alpine Immune Sciences, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 2026300000 |
| Thursday, January 1, 2015 | 6844000 | 2682700000 |
| Friday, January 1, 2016 | 8586000 | 2810000000 |
| Sunday, January 1, 2017 | 6079000 | 2582000000 |
| Monday, January 1, 2018 | 8362000 | 2473000000 |
| Tuesday, January 1, 2019 | 9467000 | 2554000000 |
| Wednesday, January 1, 2020 | 10899000 | 2367000000 |
| Friday, January 1, 2021 | 14560000 | 2624000000 |
| Saturday, January 1, 2022 | 17968000 | 2625000000 |
| Sunday, January 1, 2023 | 22222000 | 2917000000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Bausch Health Companies Inc. from 2014 to 2023.
Alpine Immune Sciences, a burgeoning biotech firm, has seen its SG&A expenses grow nearly tenfold over the past decade, reflecting its aggressive expansion and investment in innovation. In 2014, their expenses were a modest $2.3 million, but by 2023, they soared to over $22 million. This represents a staggering 870% increase, underscoring their commitment to growth.
Conversely, Bausch Health, a giant in the pharmaceutical industry, maintained a relatively stable SG&A expenditure, fluctuating around the $2.5 billion mark. This stability highlights their established market presence and efficient cost management.
These contrasting trends offer a fascinating glimpse into the strategic priorities of two distinct players in the healthcare sector.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Bausch Health Companies Inc.
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.